Science News: FDA Update, ADHD, Poverty and Suicide, and Antidepressant Withdrawal

This week, Peter Simons provides an update on the FDA's controversial approval of Alzheimer's drug aducanumab, a new guideline for psychoeducation about ADHD, a study linking poverty rates and youth suicide, and an article providing essential information about antidepressant withdrawal. Federal Investigation into FDA Approval of Alzheimer’s Drug Guideline for Education about ADHD Poverty Rates in US Counties Predict Youth Suicide Risk Four Essential Studies on Antidepressant Withdrawal Every Prescriber Must Read

This week, Peter Simons provides an update on the FDA's controversial approval of Alzheimer's drug aducanumab, a new guideline for psychoeducation about ADHD, a study linking poverty rates and youth suicide, and an article providing essential information about antidepressant withdrawal. Federal Investigation into FDA Approval of Alzheimer’s Drug Guideline for Education about ADHD Poverty Rates in US Counties Predict Youth Suicide Risk Four Essential Studies on Antidepressant Withdrawal Every Prescriber Must Read